Literature DB >> 22208617

Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer.

Xiaoxuan Liu1, Cheng Liu, Erik Laurini, Paola Posocco, Sabrina Pricl, Fanqi Qu, Palma Rocchi, Ling Peng.   

Abstract

Successful achievement of RNA interference in therapeutic applications requires safe and efficient vectors for siRNA delivery. In the present study, we demonstrate that a triethanolamine (TEA)-core PAMAM dendrimer of generation 5 (G(5)) is able to deliver sticky siRNAs bearing complementary A(n)/T(n) 3'-overhangs effectively to a prostate cancer model in vitro and in vivo and produce potent gene silencing of the heat shock protein 27, leading to a notable anticancer effect. The complementary A(n)/T(n) (n = 5 or 7) overhangs characteristic of these sticky siRNA molecules help the siRNA molecules self-assemble into "gene-like" longer double-stranded RNAs thus endowing a low generation dendrimer such as G(5) with greater delivery capacity. In addition, the A(n)/T(n) (n = 5 or 7) overhangs act as protruding molecular arms that allow the siRNA molecule to enwrap the dendrimer and promote a better interaction and stronger binding, ultimately contributing toward the improved delivery activity of G(5). Consequently, the low generation dendrimer G(5) in combination with sticky siRNA therapeutics may constitute a promising gene silencing-based approach for combating castration-resistant prostate tumors or other cancers and diseases, for which no effective treatment currently exists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22208617     DOI: 10.1021/mp2006104

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  22 in total

1.  Cationic Dendrimers for siRNA Delivery: Computational Approaches for Characterization.

Authors:  Domenico Marson; Suzana Aulic; Maurizio Fermeglia; Erik Laurini; Sabrina Pricl
Journal:  Methods Mol Biol       Date:  2021

2.  Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells.

Authors:  Leyuan Xu; Shannon Kittrell; W Andrew Yeudall; Hu Yang
Journal:  Nanomedicine (Lond)       Date:  2016-10-26       Impact factor: 5.307

Review 3.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

4.  Cationic Dendrimers for siRNA Delivery: An Overview of Methods for In Vitro/In Vivo Characterization.

Authors:  Erik Laurini; Suzana Aulic; Domenico Marson; Maurizio Fermeglia; Sabrina Pricl
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Exploiting microRNAs As Cancer Therapeutics.

Authors:  Tamsin Robb; Glen Reid; Cherie Blenkiron
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

6.  Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.

Authors:  Yin Tang; Yang-Bing Li; Bo Wang; Ri-Yuan Lin; Mallory van Dongen; Danielle M Zurcher; Xiao-Yan Gu; Mark M Banaszak Holl; George Liu; Rong Qi
Journal:  Mol Pharm       Date:  2012-05-14       Impact factor: 4.939

7.  Rapid Exchange Between Free and Bound States in RNA-Dendrimer Polyplexes: Implications on the Mechanism of Delivery and Release.

Authors:  Anisha Shakya; Casey A Dougherty; Yi Xue; Hashim M Al-Hashimi; Mark M Banaszak Holl
Journal:  Biomacromolecules       Date:  2015-12-11       Impact factor: 6.988

8.  Recent advances in targeted drug delivery approaches using dendritic polymers.

Authors:  Jason Bugno; Hao-jui Hsu; Seungpyo Hong
Journal:  Biomater Sci       Date:  2014-12-11       Impact factor: 6.843

9.  The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cells.

Authors:  Wenwen Shen; Mallory A van Dongen; Yingchun Han; Maomao Yu; Yanzhi Li; George Liu; Mark M Banaszak Holl; Rong Qi
Journal:  Eur J Pharm Biopharm       Date:  2014-07-30       Impact factor: 5.571

10.  Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.

Authors:  Vikash Reebye; Pål Sætrom; Paul J Mintz; Kai-Wen Huang; Piotr Swiderski; Ling Peng; Cheng Liu; Xiaoxuan Liu; Steen Lindkaer-Jensen; Dimitris Zacharoulis; Nikolaos Kostomitsopoulos; Noriyuki Kasahara; Joanna P Nicholls; Long R Jiao; Madhava Pai; Duncan R Spalding; Malkhaz Mizandari; Tinatin Chikovani; Mohamed M Emara; Abdelali Haoudi; Donald A Tomalia; John J Rossi; Nagy A Habib
Journal:  Hepatology       Date:  2013-12-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.